10-Q Filing

CVS HEALTH CORP CIK: 64803 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0000064803-20-000041`
Period End Date	20200930
Filing Date	20201106
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	cvs-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 86 Cash Flow Statement 91 Stockholders Equity 79 Comprehensive Income 40

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.68B	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.26B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.83B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.37B	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$23.82B	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$19.62B	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.52B	USD	Point-in-time
Inventories	`InventoryNet`	$17.48B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.83B	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.11B	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$59.21B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.30B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$20.22B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$17.31B	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	1.31B	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.04B	USD	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	423.00M	shares	Point-in-time
Treasury Stock, Shares	`TreasuryStockShares`	425.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.35B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.86B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.48B	USD	Point-in-time
Goodwill	`Goodwill`	$79.58B	USD	Point-in-time
Goodwill	`Goodwill`	$79.75B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$31.70B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.46B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.79B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.57B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.60B	USD	Point-in-time
Total assets	`Assets`	$232.90B	USD	Point-in-time
Total assets	`Assets`	$222.45B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.49B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$11.68B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$13.60B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.72B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.88B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.59B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$3.96B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.99B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$14.33B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.13B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.53B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.83B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.79B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.60B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$3.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$5.44B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$62.04B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$53.30B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.93B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.49B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$64.70B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$61.55B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.25B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.29B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.46B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.79B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.13B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.44B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.16B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.52B	USD	Point-in-time
Total liabilities	`Liabilities`	$163.79B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.28B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,309 shares outstanding at September 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.97B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,732 shares issued and 1,309 shares outstanding at September 30, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.39B	USD	Point-in-time
Treasury stock, at cost: 423 shares at September 30, 2020 and 425 shares at December 31, 2019	`TreasuryStockValue`	$28.16B	USD	Point-in-time
Treasury stock, at cost: 423 shares at September 30, 2020 and 425 shares at December 31, 2019	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$49.33B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.11B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.25B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$63.86B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$68.81B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$305.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.11B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$222.45B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$232.90B	USD	Point-in-time

Income Statement 86 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$47.61B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$15.54B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$51.75B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$17.18B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$805.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$263.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$204.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$550.00M	USD	3 Qtrs
Total revenues	`Revenues`	$64.81B	USD	1 Quarter
Total revenues	`Revenues`	$199.15B	USD	3 Qtrs
Total revenues	`Revenues`	$67.06B	USD	1 Quarter
Total revenues	`Revenues`	$189.89B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$116.65B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$121.53B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.94B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.44B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$14.40B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$12.85B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$40.53B	USD	3 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$39.40B	USD	3 Qtrs
Operating expenses	`OperatingExpenses`	$24.89B	USD	3 Qtrs
Operating expenses	`OperatingExpenses`	$8.47B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.60B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$25.70B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$61.88B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$187.76B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$180.94B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$63.81B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.25B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$8.95B	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$11.39B	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$2.93B	USD	1 Quarter
Interest expense	`InterestExpense`	$731.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.23B	USD	3 Qtrs
Interest expense	`InterestExpense`	$747.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.30B	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	Point-in-time
Other income	`OtherNonoperatingIncomeExpense`	$153.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$54.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$93.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$31.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.81B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.13B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$8.54B	USD	3 Qtrs
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$6.66B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$1.78B	USD	3 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$604.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$587.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$2.33B	USD	3 Qtrs
Net income	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.22B	USD	1 Quarter
Net income	`ProfitLoss`	$6.22B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.53B	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.53B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$6.21B	USD	3 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$4.89B	USD	3 Qtrs
Net income attributable to CVS Health	`NetIncomeLoss`	$1.22B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$0.93	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$4.74	USD	3 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$3.76	USD	3 Qtrs
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.17	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.17	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.72	USD	3 Qtrs
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.93	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.75	USD	3 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	3 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	3 Qtrs
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	3 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	3 Qtrs
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.50	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.50	USD	3 Qtrs

Cash Flow Statement 91 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$184.52B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$195.55B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$109.96B	USD	3 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$116.59B	USD	3 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$38.81B	USD	3 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$40.22B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$21.41B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$22.18B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$756.00M	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$622.00M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.52B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.67B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$2.37B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$2.21B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.30B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.21B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.79B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.62B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.01B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.38B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.89B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.72B	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$828.00M	USD	3 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$361.00M	USD	3 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinesses`	-	USD	3 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinesses`	$834.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-5.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-16.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.30B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.63B	USD	3 Qtrs
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$350.00M	USD	3 Qtrs
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	-	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$7.92B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.46B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$10.49B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$8.35B	USD	3 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$7.00M	USD	Point-in-time
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$7.00M	USD	3 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$25.00M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.95B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.98B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$183.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$249.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$75.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$85.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-33.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$11.00M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.41B	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.42B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$3.58B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.17B	USD	3 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.47B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$9.53B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.47B	USD	Point-in-time
Net income	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.22B	USD	1 Quarter
Net income	`ProfitLoss`	$6.22B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.53B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.30B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.27B	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$355.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$288.00M	USD	3 Qtrs
(Gain) loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-205.00M	USD	1 Quarter
(Gain) loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$271.00M	USD	3 Qtrs
(Gain) loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$-205.00M	USD	3 Qtrs
(Gain) loss on sale of subsidiary	`GainLossOnSaleOfBusiness`	$271.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	Point-in-time
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-79.00M	USD	3 Qtrs
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	1 Quarter
Loss on early extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-766.00M	USD	Point-in-time
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-25.00M	USD	3 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-38.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.56B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.31B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-413.00M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-45.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$211.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$374.00M	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.50B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.33B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$535.00M	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$-474.00M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$859.00M	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.73B	USD	3 Qtrs

Stockholders Equity 79 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury Stock, Value, Shares Held In Trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Common Stock, Value, Issued	`CommonStockValue`	$17.00M	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.11B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Cumulative adjustment to retained earnings as a result of new accounting standard adoption	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.11B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.53B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.22B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.43B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$2.01B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.93B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$2.99B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$236.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$42.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$848.00M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$266.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$135.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$96.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$208.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$112.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$104.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$7.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$71.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$50.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$53.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$36.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$53.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$662.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$659.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$664.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$657.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$649.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-23.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-12.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$23.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$62.93B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$68.36B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$69.11B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time

Comprehensive Income 40 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$4.89B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.22B	USD	1 Quarter
Net income	`ProfitLoss`	$6.22B	USD	3 Qtrs
Net income	`ProfitLoss`	$1.53B	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$721.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$136.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$257.00M	USD	3 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$44.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$153.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$157.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-15.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-23.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-30.00M	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$1.00M	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$236.00M	USD	3 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$42.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$848.00M	USD	3 Qtrs
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$266.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$526.00M	USD	1 Quarter
Other comprehensive income	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.26B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.45B	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.79B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.74B	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.00M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.00M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.27B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$6.44B	USD	3 Qtrs
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.80B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$5.74B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.